GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EGEIRO Pharma (XPAR:ALVET) » Definitions » Total Debt per Share

EGEIRO Pharma (XPAR:ALVET) Total Debt per Share : €0.36 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is EGEIRO Pharma Total Debt per Share?

€0.36 (As of Dec. 2023)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. EGEIRO Pharma's Total Debt Per Share for the quarter that ended in Dec. 2023 was €0.36.


EGEIRO Pharma Total Debt per Share Historical Data

The historical data trend for EGEIRO Pharma's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EGEIRO Pharma Total Debt per Share Chart

EGEIRO Pharma Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Debt per Share
0.11 0.22 0.31 0.33 0.36

EGEIRO Pharma Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 0.33 0.31 0.36 -

EGEIRO Pharma Total Debt per Share Calculation

EGEIRO Pharma's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

EGEIRO Pharma's Total Debt Per Share for the quarter that ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EGEIRO Pharma Total Debt per Share Related Terms

Thank you for viewing the detailed overview of EGEIRO Pharma's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


EGEIRO Pharma Business Description

Traded in Other Exchanges
N/A
Address
Avenue Jean Mermoz 32/1, Gosselies, BEL, 6041
EGEIRO Pharma is a biopharmaceutical company. The company is focused on the clinical development of drugs for Idiopathic Pulmonary Fibrosis, a chronic, devastating, and fatal disease characterized by the deterioration of lung function.

EGEIRO Pharma Headlines

No Headlines